Osteoporosis: Point-of-Care Testing

Annals of Pharmacotherapy

Volumn 38, Issue 3, 2004, Pages 473-481

  DeHart, Renee M ^a   Gonzalez, English H ^b  

^a SAMFORD UNIVERSITY   (United States)

^b Medical Center East   (United States)

Author keywords

Osteoporosis; Point of care testing

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; NORETHISTERONE ACETATE; VITAMIN D;

ARTICLE; BONE RADIOGRAPHY; DEVICE; DIAGNOSTIC APPROACH ROUTE; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; HUMAN; MEDICAL CARE; MEDICAL LITERATURE; MEDLINE; OSTEOPOROSIS; PHARMACIST; POINT OF CARE TESTING; PRIORITY JOURNAL; PUBLICATION; QUANTITATIVE DIAGNOSIS; QUANTITATIVE ULTRASOUND; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

ALENDRONATE; CALCITONIN; DENSITOMETRY, X-RAY; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY;

EID: 1242271394     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D229     Document Type: Review

References (43)

1. Elliott ME, Meek PD, Kanous NL, Schill GR, Weinswig PA, Bohlman JP, et al. Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc (Wash) 2002;42:101-10; quiz 110-1.
2. Faulkner KG. Update on bone density measurement. Rheum Dis Clin North Am 2001;27:81-99.
3. Osteoporosis Clinical Updates. Clinical uses of ultrasound: National Osteoporosis Foundation, 2002:1-6.
4. Gonnelli S, Cepollaro C, Montagnani A, Martini S, Gennari L, Mangeri M, et al. Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study. Osteoporos Int 2002;13:415-21.
5. Brunader R, Shelton DK. Radiologic bone assessment in the evaluation of osteoporosis. Am Fam Physician 2002;65:1357-64.
6. Drysdale IP, Hinkley HJ, Shale M, Bird D, Walters NJ. Bilateral variation in calcaneal broadband ultrasound attenuation. Part II: as measured by three bone densitometers employing ultrasound or X-ray. J Clin Densitom 2001;4:337-41.
7. Saleh MM, Jorgensen HL, Lauritzen JB. Odds ratios for hip- and lower forearm fracture using peripheral bone densitometry; a case-control study of postmenopausal women. Clin Physiol Funct Imaging 2002;22:58-63.
8. Mulder JE, Michaeli D, Flaster ER, Siris E. Comparison of bone mineral density of the phalanges, lumbar spine, hip, and forearm for the assessment of osteoporosis in postmenopausal women. J Clin Densitom 2000;3:373-81.
9. Pouilles JM, Tremollieres FA, Martinez S, Delsol M, Ribot C. Ability of peripheral DXA measurements of the forearm to predict low axial bone mineral density at menopause. Osteoporos Int 2001;12:71-6.
10. Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, et al. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1997;157:629-34.
11. Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996;348:511-4.
12. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001;286:2815-22.
13. Gonnelli S, Cepollaro C, Agnusdei D, Palmieri R, Rossi S, Gennari C. Diagnostic value of ultrasound analysis and bone densitometry as predictors of vertebral deformity in postmenopausal women. Osteoporos Int 1995;5:413-8.
14. Cepollaro C, Gonnelli S, Pondrelli C, Martini S, Montagnani A, Rossi S, et al. The combined use of ultrasound and densitometry in the prediction of vertebral fracture. Br J Radiol 1997;70:691-6.
15. Wuster C, Albanese C, De Aloysio D, Duboeuf F, Gambacciani M, Gonnelli S, et al. Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res 2000;15:1603-14.
16. Ekman A, Michaelsson K, Petren-Mallmin M, Ljunghall S, Mallmin H. DXA of the hip and heel ultrasound but not densitometry of the fingers can discriminate female hip fracture patients from controls: a comparison between four different methods. Osteoporos Int 2001;12:185-91.
17. Ingle BM, Sherwood KE, Eastell R. Comparison of two methods for measuring ultrasound properties of the heel in postmenopausal women. Osteoporos Int 2001;12:500-5.
18. Alenfeld FE, Engelke K, Schmidt D, Brezger M, Diessel E, Felsenberg D. Diagnostic agreement of two calcaneal ultrasound devices: the Sahara bone sonometer and the Achilles+. Br J Radiol 2002;75:895-902.
19. Cheng S, Njeh CF, Fan B, Cheng X, Hans D, Wang L, et al. Influence of region of interest and bone size on calcaneal BMD: implications for the accuracy of quantitative ultrasound assessments at the calcaneus. Br J Radiol 2002;75:59-68.
20. Frost ML, Blake GM, Fogelman I. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis. J Bone Miner Res 2001;16:406-16.
21. Hartl F, Tyndall A, Kraenzlin M, Bachmeier C, Guckel C, Senn U, et al. Discriminatory ability of quantitative ultrasound parameters and bone mineral density in a population-based sample of postmenopausal women with vertebral fractures: results of the Basel Osteoporosis Study. J Bone Miner Res 2002;17:321-30.
22. Greenspan SL, Bouxsein ML, Melton ME, Kolodny AH, Clair JH, Delucca PT, et al. Precision and discriminatory ability of calcaneal bone assessment technologies. J Bone Miner Res 1997;12:1303-13.
23. Bachman DM, Crewson PE, Lewis RS. Comparison of heel ultrasound and finger DXA to central DXA in the detection of osteoporosis. Implications for patient management. J Clin Densitom 2002;5:131-41.
24. Varney LF, Parker RA, Vincelette A, Greenspan SL. Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis. J Clin Densitom 1999;2:275-83.
25. Jorgensen HL, Warming L, Bjarnason NH, Andersen PB, Hassager C. How does quantitative ultrasound compare to dual X-ray absorptiometry at various skeletal sites in relation to the WHO diagnosis categories? Clin Physiol 2001;21:51-9.
26. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.
27. Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom 1999;2:343-50.
28. Ayers M, Prince M, Ahmadi S, Baran DT. Reconciling quantitative ultrasound of the calcaneus with X-ray-based measurements of the central skeleton. J Bone Miner Res 2000;15:1850-5.
29. Adler RA, Funkhouser HL, Holt CM. Utility of heel ultrasound bone density in men. J Clin Densitom 2001;4:225-30.
30. Goemaere S, Zmierczak H, Van Pottelbergh I, Kaufman JM. Ability of peripheral bone assessments to predict areal bone mineral density at hip in community-dwelling elderly men. J Clin Densitom 2002;5:219-28.
31. Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Rossi S, Gennari C. Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study. Osteoporos Int 1996;6:303-7.
32. Gonnelli S, Cepollaro C, Montagnani A, Martini S, Gennari L, Mangeri M, et al. Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study. Osteoporos Int 2002;13:415-21.
33. Rosenthall L, Caminis J, Tenehouse A. Calcaneal ultrasonometry: response to treatment in comparison with dual x-ray absorptiometry measurements of the lumbar spine and femur. Calcif Tissue Int 1999;64:200-4.
34. Sahota O, San P, Cawte SA, Pearson D, Hosking DJ. A comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: the four-year effects of hormone replacement therapy. Osteoporos Int 2000;11:52-8.
35. Drake WM, Brown JP, Banville C, Kendler DL. Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal women. Osteoporos Int 2002;13:249-56.
36. Gonnelli S, Cepollaro C. The use of ultrasound in the assessment of bone status. J Endocrinol Invest 2002;25:389-97.
37. Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Montagnani A, Monaco R, et al. Bone turnover and the response to alendronate treatment in post-menopausal osteoporosis. Calcif Tissue Int 1999;65:359-64.
38. Miller PD, Njeh CF, Jankowski LG, Lenchik L. What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis? J Clin Densitom 2002;5 (suppl):S39-45.
39. Elliott ME, Meek PD, Kanous NL, Schill GR, Weinswig PA, Bohlman JP, et al. Pharmacy-based bone mass measurement to assess osteoporosis risk. Ann Pharmacother 2002;36:571-7. DOI 10.1345/aph.1A299
40. International classification of diseases. 9th rev. Clinical modification. vol 1 and 2. Chicago: American Medical Association, 2002:805.
41. Rosenthal WM. Implementing bone mineral density testing in the community pharmacy. J Am Pharm Assoc (Wash) 2000;40:737-45.
42. Lippuner K, Fuchs G, Ruetsche AG, Perrelet R, Casez JP, Neto I. How well do radiographic absorptiometry and quantitative ultrasound predict osteoporosis at spine or hip? A cost-effectiveness analysis. J Clin Densitom 2000;3:241-9.
43. Langton CM, Langton DK, Beardsworth SA. Comparison of accuracy and cost effectiveness of clinical criteria and BUA for referral for BMD assessment by DXA in osteoporotic and osteopenic perimenopausal subjects. Technol Health Care 1999;7:319-30.